Cannabinoid Encyclopedia

How cannabinoids work

What is the CB1 receptor?

CB1, or cannabinoid receptor 1, is a biological target studied throughout the brain and body. This guide explains its function, cannabinoid signaling, and why receptor activity is not itself a health outcome.

Updated July 2026 56 research sources Mostly early-stage research

The short answer

Where CB1 fits into cannabinoid biology

CB1 is a biological target studied to understand how cannabinoids affect cells and signaling. Research on Cannabinoids, Endocannabinoids, and HHC helps explain possible mechanisms. This page brings together 12 human-study sources, 28 research reviews, and 16 lab, animal, or mechanism sources. Most of the current evidence is preclinical or focused on biological mechanisms. A mechanism alone does not prove that a cannabinoid will produce a health benefit in people. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about CB1.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on CB1 covers Cannabinoids, Endocannabinoids, and HHC; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about CB1

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly mechanism-focused

Cannabinoids

Studies examine how Cannabinoids connects with CB1 or closely related target biology. These findings help explain signaling and pharmacology, not a guaranteed health effect. 2

Mostly mechanism-focused

Endocannabinoids

Studies examine how Endocannabinoids connects with CB1 or closely related target biology. These findings help explain signaling and pharmacology, not a guaranteed health effect. 3

Mostly mechanism-focused

HHC

Studies examine how HHC connects with CB1 or closely related target biology. These findings help explain signaling and pharmacology, not a guaranteed health effect. 4

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

12 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

28 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

16 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on CB1 is not one kind of study. This source set includes 27 narrative or expert reviews, 18 animal studies, 3 cell or laboratory studies, and 1 clinical study in people. 3

The recorded populations or models include people or patients (16 sources), animal models (11 sources), and cells or tissue models (10 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is cB1 receptor pharmacology, ligand binding, or signaling mechanisms (33 sources) and cB1 neurobehavioral, appetite, metabolic, pain, cognition, or synaptic mechanisms (24 sources). Closely related outcome names can still describe different measurements. 5

The CB1 source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

narrative or expert review

Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities.

On this page, this source examines Cannabinoids activity involving CB1. 1

Study type
narrative or expert review
Outcome focus
cB1 neurobehavioral, appetite, metabolic, pain, cognition, or synaptic mechanisms
Evidence stage
evidence still limited

cell or laboratory study

Oxa-adamantyl cannabinoids.

On this page, this source examines Cannabinoids activity involving CB1. 2

Study type
cell or laboratory study
Population or model
cells or tissue models
Outcome focus
cB1 receptor pharmacology, ligand binding, or signaling mechanisms
Evidence stage
evidence still limited

narrative or expert review

Cannabinergic ligands.

On this page, this source examines Endocannabinoids activity involving CB1. 3

Study type
narrative or expert review
Population or model
cells or tissue models
Outcome focus
cB1 receptor pharmacology, ligand binding, or signaling mechanisms
Evidence stage
evidence still limited

mechanism-focused research

Crystal structures of agonist-bound human cannabinoid receptor CB1.

On this page, this source examines HHC activity involving CB1. 4

Population or model
people or patients
Outcome focus
cB1 receptor pharmacology, ligand binding, or signaling mechanisms
Evidence stage
mechanism-focused research

systematic review or meta-analysis

The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species.

On this page, this source examines THC activity involving CB1. 5

Study type
systematic review or meta-analysis
Population or model
people or patients
Outcome focus
cB1 neurobehavioral, appetite, metabolic, pain, cognition, or synaptic mechanisms
Evidence stage
evidence still limited

Safety and limits

What should readers keep in mind?

Research on CB1 should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What does CB1 do?

CB1 is studied as part of cannabinoid-related biology and signaling. The exact role depends on the tissue, compound, and experimental setting. 7

Does a biological mechanism prove a health effect?

No. A mechanism can explain why an idea is plausible, but human studies are needed to test whether it changes a health outcome. 8

What research is linked to CB1?

The main areas on this page include Cannabinoids, Endocannabinoids, and HHC. The source links show the study type behind each area. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities. narrative or expert review; evidence still limited PubMed 31771126 DOI 10.3390/ijms20235874
  2. 2
    Oxa-adamantyl cannabinoids. cell or laboratory study; evidence still limited PubMed 33636308 DOI 10.1016/j.bmcl.2021.127882
  3. 3
    Cannabinergic ligands. narrative or expert review; evidence still limited PubMed 12505686 DOI 10.1016/s0009-3084(02
  4. 4
    Crystal structures of agonist-bound human cannabinoid receptor CB1. mechanism-focused research PubMed 40866700 DOI 10.1038/s41586-025-09454-5
  5. 5
    The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species. systematic review or meta-analysis; evidence still limited PubMed 31165913 DOI 10.1007/s00213-019-05283-3
  6. 6
    Cross state-dependent memory retrieval between cannabinoid CB1 and serotonergic 5-HT1A receptor agonists in the mouse dorsal hippocampus. clinical study in people; mechanism-focused research PubMed 35595026 DOI 10.1016/j.nlm.2022.107638
  7. 7
    Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor. narrative or expert review; evidence still limited PubMed 27879006 DOI 10.1002/med.21418
  8. 8
    Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity. narrative or expert review; evidence still limited PubMed 29355030 DOI 10.1080/03602532.2018.1428342
  9. 9
    Analysis of the endocannabinoid system by using CB1 cannabinoid receptor knockout mice. narrative or expert review; evidence still limited PubMed 16596773 DOI 10.1007/3-540-26573-2_4
  10. 10
    Astroglial type-1 cannabinoid receptor (CB1): A new player in the tripartite synapse. narrative or expert review; evidence still limited PubMed 25967266 DOI 10.1016/j.neuroscience.2015.05.002
  11. 11
    Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. narrative or expert review; evidence still limited PubMed 18537620 DOI 10.2174/092986708784567716
  12. 12
    Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery? narrative or expert review; evidence still limited PubMed 20590557 DOI 10.1111/j.1476-5381.2010.00777.x
See all 56 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Oxa-adamantyl cannabinoids. cell or laboratory study; evidence still limited / 1 linked research note PubMed 33636308
  2. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. narrative or expert review; evidence still limited / 1 linked research note PubMed 18537620
  3. Pharmacological actions of cannabinoids. narrative or expert review; evidence still limited / 1 linked research note PubMed 16596770
  4. Crystal structures of agonist-bound human cannabinoid receptor CB1. mechanism-focused research / 1 linked research note PubMed 40866700
  5. Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation. animal study; mechanism-focused research / 1 linked research note PubMed 35489334
  6. Snapshot of the cannabinoid receptor 1-arrestin complex unravels the biased signaling mechanism. mechanism-focused research / 1 linked research note PubMed 38101408
  7. A cryptic pocket in CB1 drives peripheral and functional selectivity. animal study; mechanism-focused research / 1 linked research note PubMed 40044849
  8. Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities. narrative or expert review; evidence still limited / 2 linked research notes PubMed 28527758
  9. Cannabinergic ligands. narrative or expert review; evidence still limited / 1 linked research note PubMed 12505686
  10. Assay of CB1 Receptor Binding. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 27245890
  11. Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1. animal study; mechanism-focused research / 1 linked research note PubMed 38830102
  12. Pharmacology of cannabinoid receptor ligands. narrative or expert review; evidence still limited / 1 linked research note PubMed 10469884
  13. Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor. narrative or expert review; evidence still limited / 1 linked research note PubMed 27879006
  14. The CB1 cannabinoid receptor in the brain. narrative or expert review; evidence still limited / 1 linked research note PubMed 9974174
  15. CB1 Cannabinoid Receptor Signaling and Biased Signaling. narrative or expert review; evidence still limited / 1 linked research note PubMed 34500853
  16. Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor. narrative or expert review; evidence still limited / 1 linked research note PubMed 30333554
  17. Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 22343625
  18. CB1 Receptor Negative Allosteric Modulators as a Potential Tool to Reverse Cannabinoid Toxicity. animal study; mechanism-focused research / 1 linked research note PubMed 38675703
  19. Allosteric modulation of the cannabinoid CB1 receptor. animal study; mechanism-focused research / 1 linked research note PubMed 16113085
  20. Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation. animal study; mechanism-focused research / 1 linked research note PubMed 31968549
  21. Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor. animal study; mechanism-focused research / 1 linked research note PubMed 28103441
  22. Endocannabinoids and Their Pharmacological Actions. narrative or expert review; evidence still limited / 1 linked research note PubMed 26408156
  23. The future of type 1 cannabinoid receptor allosteric ligands. mechanism-focused research / 1 linked research note PubMed 29355038
  24. Diarylureas as allosteric modulators of the cannabinoid CB1 receptor: structure-activity relationship studies on 1-(4-chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1). mechanism-focused research / 1 linked research note PubMed 25162172
  25. Crystal structures of agonist-bound human cannabinoid receptor CB1. mechanism-focused research / 1 linked research note PubMed 28678776
  26. Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity. narrative or expert review; evidence still limited / 1 linked research note PubMed 29355030
  27. Synthetic Cannabinoids. narrative or expert review; evidence still limited / 1 linked research note PubMed 26132518
  28. Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery. narrative or expert review; evidence still limited / 1 linked research note PubMed 39828030
  29. Structural mechanism of CB1R binding to peripheral and biased inverse agonists. mechanism-focused research / 1 linked research note PubMed 39695122
  30. Targeting mechanosensitive cannabinoid receptor 1 with isoflavone prodrugs attenuates atherosclerotic endothelial dysfunction. animal study; mechanism-focused research / 1 linked research note PubMed 41559687
  31. Synthesis and Pharmacological Characterization of a Novel Cannabinoid Receptor 1 Antagonist. animal study; mechanism-focused research / 1 linked research note PubMed 40521518
  32. Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists. narrative or expert review; evidence still limited / 1 linked research note PubMed 33811300
  33. Computational Analysis of Dipyrone Metabolite 4-Aminoantipyrine As A Cannabinoid Receptor 1 Agonist. narrative or expert review; evidence still limited / 1 linked research note PubMed 31490743
  34. New Insights in Cannabinoid Receptor Structure and Signaling. narrative or expert review; evidence still limited / 1 linked research note PubMed 30767756
  35. Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery? narrative or expert review; evidence still limited / 1 linked research note PubMed 20590557
  36. Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review. narrative or expert review; evidence still limited / 1 linked research note PubMed 34050525
  37. Endocannabinoid System: A Multi-Facet Therapeutic Target. narrative or expert review; evidence still limited / 1 linked research note PubMed 27086601
  38. CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a. animal study; mechanism-focused research / 1 linked research note PubMed 17895407
  39. Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities. narrative or expert review; evidence still limited / 1 linked research note PubMed 31771126
  40. The pharmacology of cannabinoid receptors and their ligands: an overview. narrative or expert review; evidence still limited / 1 linked research note PubMed 16570099
  41. Latest advances in cannabinoid receptor agonists. narrative or expert review; evidence still limited / 1 linked research note PubMed 19939187
  42. Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. narrative or expert review; evidence still limited / 1 linked research note PubMed 19285266
  43. Therapeutic potential of cannabinoid receptor 2 in the treatment of diabetes mellitus and its complications. narrative or expert review; evidence still limited / 1 linked research note PubMed 31461639
  44. The endocannabinoid system: physiology and pharmacology. narrative or expert review; evidence still limited / 1 linked research note PubMed 15550444
  45. Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism. animal study; mechanism-focused research / 1 linked research note PubMed 36088492
  46. Role of the cannabinoid CB1 receptor in methamphetamine-induced social and recognition memory impairment. animal study; mechanism-focused research / 1 linked research note PubMed 35429587
  47. Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models. animal study; mechanism-focused research / 1 linked research note PubMed 40855505
  48. Adipocyte cannabinoid CB1 receptor deficiency alleviates high fat diet-induced memory deficit, depressive-like behavior, neuroinflammation and impairment in adult neurogenesis. animal study; mechanism-focused research / 1 linked research note PubMed 31491589
  49. Astroglial type-1 cannabinoid receptor (CB1): A new player in the tripartite synapse. narrative or expert review; evidence still limited / 1 linked research note PubMed 25967266
  50. A cannabinoid link between mitochondria and memory. animal study; mechanism-focused research / 1 linked research note PubMed 27828947
  51. Pharmacological inhibition of the CB1 cannabinoid receptor restores abnormal brain mitochondrial CB1 receptor expression and rescues bioenergetic and cognitive defects in a female mouse model of Rett syndrome. animal study; mechanism-focused research / 1 linked research note PubMed 39300547
  52. The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 31165913
  53. Cross state-dependent memory retrieval between cannabinoid CB1 and serotonergic 5-HT1A receptor agonists in the mouse dorsal hippocampus. clinical study in people; mechanism-focused research / 1 linked research note PubMed 35595026
  54. Adenosine receptors are the on-and-off switch of astrocytic cannabinoid type 1 (CB1) receptor effect upon synaptic plasticity in the medial prefrontal cortex. animal study; mechanism-focused research / 1 linked research note PubMed 38482984
  55. Hippocampal Deletion of CB1 Receptor Impairs Social Memory and Leads to Age-Related Changes in the Hippocampus of Adult Mice. animal study; mechanism-focused research / 1 linked research note PubMed 36613469
  56. Analysis of the endocannabinoid system by using CB1 cannabinoid receptor knockout mice. narrative or expert review; evidence still limited / 1 linked research note PubMed 16596773